Protara Therapeutics, Inc. — Director's Dealing 2017

Nov 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2017-11-14

Reporting Person: Eldridge, George Arthur (Sr VP, CFO, Treasr, Asst Secy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-14	Common Stock	P	295	$1.69	Acquired	1545	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12750	Direct

Footnotes

F1: These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.